Drug reference
isoproterenol
Potent nonselective β adrenergic receptor agonist · Cardiostimulant, Bronchodilator
Potent nonselective β adrenergic receptor agonistCardiostimulant, BronchodilatorATC C01CA02
CDSCO approvedATC C01CA02
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Isoproterenol is a potent nonselective β adrenergic receptor agonist with very low affinity for α receptors. It lowers peripheral vascular resistance, decreases diastolic pressure, and increases cardiac output due to positive inotropic and chronotropic effects. It relaxes almost all varieties of smooth muscle, notably bronchial and GI smooth muscle, preventing bronchoconstriction.
Indications
stimulate heart rate in patients with bradycardia or heart block (emergencies)ventricular arrhythmia torsades de pointes (emergencies)asthma (largely replaced by other drugs)shock (largely replaced by other drugs)Bronchodilation (as last resort)
Pharmacokinetics
Protein binding
duration of action longer than epinephrine but still relatively brief
Metabolism
metabolized by COMT, primarily in the liver (poor substrate for MAO and NET)
Contraindications
- patients with coronary artery disease (cardiac ischemia)
Side effects
Common
palpitationstachycardiaheadacheflushing
Serious
- arrhythmias
- myocardial cell death (large doses in experimental animals)
Related guidelines
Ask House about isoproterenol
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team